Avicenna has been a Contract Manufacturing Organization (CMO) since its was funded in 1999. This includes:
• Contract Manufacturing of Category I and II Solid Dosage Drugs: as per client’s specifications
• Contract Manufacturing of Category III-VI Hazardous Solid Dosage Drugs: as per client’s specifications
• Avicenna Develops Novel Non-infringing Methods: to avoid wet granulation, simplify direct compression without resorting to roller compaction and provides novel formulations of existing drugs to improve bioavailability or to reduce GI side-effects. See for example doi. 10.1517/13543776.2011.569493 and WO 2017/199073 Al; US Patent  US 2019/0240144 Al; Iranian Patent 1390/07/27-71996; Iranian Patent 1393/11/13-84942
• Contract Manufacturing of New Chemical Entities for Clinical Trials: as per client’s specifications